Expression of growth factors in the gingival crevice fluid of patients with phenytoin-induced gingival enlargement

Archives of Oral Biology

Volumn 49, Issue 11, 2004, Pages 945-950

  Kuru, L ^a   Yilmaz, S ^b   Kuru, B ^a,b   Kose K N ^a   Noyan, U ^a,b  

^a MARMARA UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Gingival crevice fluid; Gingival enlargement; Growth factors; Phenytoin

Indexed keywords

ANTICONVULSIVE AGENT; FIBROBLAST GROWTH FACTOR 2; GROWTH PROMOTOR; PHENYTOIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; GINGIVA HYPERPLASIA; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; ANTICONVULSANTS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GINGIVAL CREVICULAR FLUID; GINGIVAL HYPERPLASIA; GROWTH SUBSTANCES; HUMANS; MALE; MIDDLE AGED; PHENYTOIN; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4444374871     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2004.04.010     Document Type: Article

References (38)

1. Merritt H., Putnam T. Sodium diphenylhydantoine in the treatment of convulsive disorders. J. Am. Med. Assoc. 111:1938;1068-1073
2. Hallmon W.W., Rossmann J.A. The role of drugs in the pathogenesis of gingival overgrowth. Periodontol. 2000. 21:1999;176-196
3. Angelopoulos A.P., Goaz P.W. Incidence of diphenylhydantoin gingival hyperplasia. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 34:1972;898-906
4. Dahllöf G., Modéer T. The effect of a plaque control program on the development of phenytoin-induced gingival overgrowth. A 2-year longitudinal study. J. Clin. Periodontol. 13:1986;845-849
5. Brown R.S., Beaver W.T., Bottomley W.K. On the mechanism of drug-induced gingival hyperplasia. J. Oral. Pathol. Med. 20:1991;201-209
6. Noyan Ü., Yilmaz S., Arda O. The ultrastructural comparison of phenytoin and cyclosporin A-induced gingival hyperplasia. J. Marmara Univ. Dent. Fac. 1:1991;43-46
7. Saito K., Mori S., Iwakura M., Sakamoto S. Immunohistochemical localization of transforming growth factor beta, basic fibroblast growth factor and heparan sulphate glycosaminoglycan in gingival hyperplasia induced by nifedipine and phenytoin. J. Periodont. Res. 31:1996;545-555
8. Iacopino A.M., Doxey D., Cutler C.W., Nares S., Stoever K., Fojt J., et al. Phenytoin and cyclosporine A specifically regulate macrophage and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible mechanism of drug-induced overgrowth. J. Periodontol. 68:1997;73-83
9. Dill R.E., Miller E.K., Weil T., Lesley S., Farmer G.R., Iacopino A.M. Phenytoin increases gene expression for platelet-derived growth factor B chain in macrophages and monocytes. J. Periodontol. 64:1993;169-173
10. Pagliarini A., Stabellini G., Carinci F., Calura G., Tognon M., Evangelisti R. Heterogeneity of fibroblasts derived from human free and attached gingiva. Glycosaminoglycan synthesis and effects of phenytoin (PHT) treatment. J. Oral. Pathol. Med. 24:1995;72-77
11. Kiritsy C.P., Lynch A.B., Lynch S.E. Role of growth factors in cutaneous wound healing: a review. Crit. Rev. Oral. Biol. Med. 4:1993;729-760
12. Sporn MB, Roberts AB. Polypeptide growth factors and their receptors. New York: Springer-Verlag; 1991.
13. Gressner A.M., Weiskirchen R., Breitkopf K., Dooley S. Roles of TGF-beta in hepatic fibrosis. Front Biosci. 7:2002;793-807
14. Finkelstein J.N., Johnston C.J., Baggs R., Rubin P. Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;621-631
15. Trojanowska M. Molecular aspects of scleroderma. Front Biosci. 7:2002;608-618
16. Seymour R.A., Smith D.G., Turnbull D.N. The effects of phentoin and sodium valproate on the periodontal health of adult epileptic patients. J. Clin. Periodontol. 12:1985;413-419
17. Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol. Scand. 22:1964;121-135
18. Löe H., Silness J. Periodontal disease in pregnancy. I. Prevalance and severity. Acta Odontol. Scand. 22:1963;121-126
19. Griffiths G.S., Curtis M.A., Wilton J.M. Selection of a filter paper with optimum properties for the collection of gingival crevicular fluid. J. Periodont. Res. 23:1988;33-38
20. Cimasoni G, Giannopoulou C. Can crevicular fluid component analysis assist in diagnosis and monitoring periodontal breakdown? In: Guggenheim B, editor. Periodontology today. Basel: Karger; 1988. p. 260-70.
21. Kuru L, Griffiths GS, Petrie A, Olsen I. Changes in transforming growth factor-beta 1 in gingival crevicular fluid following periodontal surgery. J Clin Periodontol 2004 (in press).
22. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258:1983;7155-7160
23. Graves D.T., Kang Y.-M., Kose K.N. Growth factors in periodontal regeneration. Compend. Contin. Educ. Dent. 18(Suppl):1994;S672-S677
24. Bartram U., Speer C.P. The role of transforming growth factor beta in lung development and disease. Chest. 125:2004;754-765
25. Chen S., Jim B., Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin. Nephrol. 23:2003;532-543
26. Calabrese F., Valente M., Giacometti C., Pettenazzo E., Benvegnu L., Alberti A., et al. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology. J. Gastroenterol. Hepatol. 18:2003;1302-1308
27. Buduneli N., Kütükçüler N., Aksu G., Atilla G. Evaluation of transforming growth factor-β1 level in gingival crevicular fluid of cyclosporine A-treated patients. J. Periodontol. 72:2001;526-531
28. Cotrim P., de Andrade C.R., Martelli-Junior H., Graner E., Sauk J.J., Coletta R.D. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation. J. Periodontol. 73:2002;1313-1322
29. Ross R., Raines E.W., Bowen-Pope D.F. The biology of platelet-derived growth factor. Cell. 4:1986;155-169
30. Deuel T.F., Kawahara R.S., Mustoe T.A., Pierce G.F. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. Ann. Rev. Med. 42:1991;567-584
31. Griffiths G.S. Formation, collection and significance of gingival crevice fluid. Periodontol. 2000. 31:2003;32-42
32. Sasaki T., Maita E. Increased bFGF level in the serum of patients with phenytoin-induced gingival overgrowth. J. Clin. Periodontol. 25:1998;42-47
33. Kuru L., Parkar M.H., Griffiths G.S., Newman H.N., Olsen I. Flow cytometry analysis of gingival and periodontal ligament cells. J. Dent. Res. 77:1998;555-564
34. Kuru L., Parkar M.H., Griffiths G.S., Olsen I. Flow cytometry analysis of regenerative human periodontal cells. J. Periodontol. 72:2001;1016-1024
35. Hefti A.F. Aspects of cell biology of the normal periodontium. Periodontol. 2000. 3:1993;64-75
36. Liljenberg B., Lindhe J., Berglundh T., Dahlén G., Jonsson R. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease. J. Clin. Periodontol. 21:1994;720-727
37. Pinheiro M.L., Feres-Filho E.J., Graves D.T., Takiya C.M., Elsas M.I., Elsas P.P., et al. Quantification and localization of platelet-derived growth factor in gingiva of periodontitis patients. J. Periodontol. 74:2003;323-328
38. Skaleric U., Kramar B., Petelin M., Pavlica Z., Wahl S.M. Changes in TGF-beta 1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur. J. Oral. Sci. 105:1997;136-142